cebranopadol (TRN-228) - Tris Pharma
ALLEVIATE2: A Study of Cebranopadol for the Treatment of Acute Pain After Bunionectomy (clinicaltrials.gov) - May 21, 2024 - P3 | N=240 | Not yet recruiting | Sponsor: Tris Pharma, Inc. 
New P3 trial • Pain
http://clinicaltrials.gov/ct2/show/NCT06423703
 
May 21, 2024
 
Prev Next